SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Cos. Develop COVID-19 Antibody Treatments

BIOTECH: Allele Biotechnology Using Nanoantibodies from Llamas

Dr. Jiwu Wang was thinking ahead when he purchased a plot of land in Fallbrook to raise llamas about 12 years ago.

Agragene Annouces $4M in Additional Funding

AGRICULTURE: New Investment Again Comes from Ospraie Ag Science

The agriculture-tech sector is growing and Agragene Inc. is attracting attention from investors.

Tease photo

Ionis Pharmaceuticals to Acquire Remaining Stake in Akcea

BIOTECH: Boston Co. Was Spun Out of Ionis, Had IPO in 2017

Ionis Pharmaceuticals plans to acquire the remaining stake in Akcea Therapeutics that it does not already own for approximately $500 million cash.

Tease photo

Aegis Life Using Its Technology to Develop DNA-Focused COVID-19 Vaccine

BIOTECH: Company Received $4.2M in Grant Funding

San Diego-based Aegis Life, a biotechnology company developing vaccines and therapies for life-threatening diseases, has entered the race to combat COVID-19 with its DNA vaccine.

Tease photo

Working to Erase Cancer

BIOTECH: Erasca Raises $236 Million

Erasca, a cancer therapeutics company seeking to eliminate cancer, has completed a $36 million extension of its Series B financing round, bringing its total Series B round to $236 million.

Tease photo

La Jolla Institute Gets $6.4M for COVID Research

BIOTECH: Investigations to Focus on Understudied Part of Antibody

The National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health, has awarded more than $6.4 million to Erica Ollmann Saphire, Ph.D., a professor at the La Jolla Institute for Immunology, to support research toward COVID-19 antibody therapeutics. The local organization announced the award on Aug. 20.

Tease photo

Inhibrx Gains $125.7M in IPO, Has Cancer in its Sights

BIOTECH: Firm Uses Protein Engineering to Develop Drug Candidates

Inhibrx Inc. completed its initial public offering on Aug. 20, gaining an estimated $125.7 million to push its business forward.

San Ysidro Health Front-Line Staff Receives Donation of Meals from Frontline Foods

On Wednesday, Aug. 26, 2020, several San Ysidro Health rural clinics in East County received a donation of meals for the organization’s front line staff from Frontline Foods as a thank you for their fearless dedication during this pandemic.

Tease photo

Diomics Developing Test to Reveal SARS-CoV-2 Antibodies

Diomics, a San Diego-based biotech company, announced on Aug. 19 that it is developing the Diocheck Antibody Indicator, which provides a simple way for individuals to monitor for the presence of antibodies to SARS-CoV-2 over an extended period of time.

Carlsbad Co. Uses RFID to Better Manage Inventory

TECH: Designs, Manufactures Healthcare Supply Chain Solutions

Ligand Inks $516M Deal

BIOTECH: Agrees To Purchase Pfenex

Tease photo

Kaiser Permanente Opens Next Generation Medical Building in Clairemont Mesa

HEALTHCARE: Facility Designed to Give Members ‘Positive Experience’

Tease photo

Runway Growth Expands to San Diego

INVESTMENT: Firm Aims to Deploy Capital to Life Science Companies

Carlsbad Medtech Firm Finds Success with IPO

Company Raises $183Million in Offering Last Week

Tease photo

COVID-19 Test in Demand

BIOTECH: Hologic On Track to Double Its Factory Capacity

Tease photo

Prev